Back To Search Results

Dermatopathology Evaluation of Metabolic and Storage Diseases

Editor: Karolyn Wanat Updated: 2/13/2025 8:57:35 PM

Introduction

Metabolism and cellular storage disorders encompass a broad, heterogeneous group of conditions with diverse etiologies, including genetic mutations and behavioral factors. These disorders often present with complex, multisystem involvement, and the skin frequently serves as a visible marker of underlying metabolic dysfunction. This comprehensive overview of key metabolic and storage disorders with cutaneous manifestations is categorized into vitamin disturbances, necrolytic erythemas, lysosomal storage diseases, mucinoses, amyloidosis, and miscellaneous conditions.

Although histopathologic evaluation can offer valuable diagnostic clues, many of the features observed are nonspecific and require careful correlation with clinical presentation and laboratory findings. Recognizing these cutaneous signs is critical, as they can be the first indication of a systemic disorder, prompting timely diagnosis and management.

Clinical Significance

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Clinical Significance

Mucinosis

Mucinoses are a group of disorders marked by the accumulation of mucin in the dermis. Mucin is generally a non-sulfated acid mucopolysaccharide (hyaluronic acid) that manifests as delicate, faintly blue threads in standard histological sections. Specialized stains, such as colloidal iron, Alcian blue, and toluidine blue, enhance the visualization of mucin for accurate diagnosis.

  • Scleredema of Buschke primarily occurs in individuals with insulin-dependent, adult-onset diabetes mellitus, typically manifesting on the upper back, a region characterized by a typically thick dermis. Scleredema may manifest abruptly following a streptococcal infection or in conjunction with a monoclonal gammopathy. Upon examination, the histologic characteristics may be subtle and resemble normal skin; nonetheless, there is an increased interstitial separation of collagen fibers in the deep dermis with mucin deposition. Notably, there is no inflammatory infiltrate or increase in fibroblast numbers.[1]
  • Pretibial myxedema occurs among patients with Graves' disease, particularly in those with exophthalmos. This condition may not manifest until after the hyperthyroidism is corrected. Large amounts of mucin are often observed throughout the dermis, leading to the separation of collagen bundles.[2]
  • Scleromyxedema (lichen myxedematosus) consists of linear arrangements of waxy papules. This variant involves the coalescence of papules along with diffuse skin sclerosis. Immunoglobulin (Ig) G lambda gammopathy is linked to scleromyxedema and several cases of papular mucinosis. The histologic characteristics of this entity include an increase in dermal fibroblasts, fine collagen fibers, and interstitial mucin.

Amyloidosis

Primary systemic amyloidosis results from the accumulation of light chains. Although skin lesions may be present, in their absence, a blind biopsy of the salivary glands or abdominal adipose tissue can be performed to detect amyloid deposits. Nodular cutaneous amyloidosis, formed from light chains, is locally produced by plasma cells and may or may not be linked to systemic amyloidosis. Secondary systemic amyloidosis is characterized by the absence of clinical skin lesions; however, it may exhibit amyloid deposits in minor salivary glands or abdominal adipose tissue. Epidermal (keratin)-derived variants of amyloidosis encompass macular and lichen amyloidosis. Amyloid has a brick red hue when stained with Congo red and an apple green coloration under polarized light. Thioflavin T staining is highly sensitive yet necessitates analysis using a fluorescent microscope, producing yellow-green fluorescence in amyloid plaques. Crystal violet is a metachromatic stain with a high affinity for amyloid generated from the epidermis.

  • Nodular amyloidosis comprises light chains (AL) and can manifest as an isolated cutaneous lesion or in conjunction with primary systemic amyloidosis. Lesions may be a manifestation of a localized plasmacytoma. Large, fissured, pale pink masses with prominent plasma cells are often present upon histopathological examination.
  • Macular amyloidosis is a keratin-derived deposition resulting from persistent scratching. Clinically, there is rippled hyperpigmentation in the interscapular region. This little deposition can be readily missed and may resemble normal skin. Amyloid is surrounded by a fine network of melanophages.[3]
  • Lichen amyloidosis is a keratin-derived deposit that histologically mimics macular amyloid, accompanied by alterations characteristic of lichen simplex chronicus. Clinically, it manifests as extremely pruritic papules arranged in rows, typically located on the front shins. Key features include hyperkeratosis and acanthosis with pink amorphous deposits in the papillary dermis outlined by a network of melanophages.

Calcinosis Cutis

Calcinosis cutis refers to the deposition of calcium in the skin and is categorized into dystrophic, metastatic, and idiopathic forms.

  • Dystrophic calcium deposition occurs in damaged tissue despite normal calcium levels, as shown in conditions such as dermatomyositis, scleroderma, or scarring. Scrotal calcinosis refers to the calcification of epidermoid cysts.
  • Metastatic calcifications manifest in normal tissue and are linked to increased serum calcium, phosphate, or both. Calciphylaxis is a distinct kind of metastatic calcification.
  • Subepidermal calcified nodules have an unidentified pathophysiology and are classified as idiopathic calcifications. Calcium deposits generally exhibit basophilia in hematoxylin- and eosin-stained sections, stain black with von Kossa silver stain, and appear red with alizarin red.[4]

Gout

The evaluation of cutaneous gout lesions often demonstrates palisaded granuloma surrounding amorphous gray material with a feathery appearance. Formalin fixation eliminates the uric acid crystals, resulting in feathery clefts. Brown crystals exhibiting double refraction under polarization are observed when the tissue has been fixed in ethanol or inadequately preserved in formalin.

Porphyria

Porphyria cutanea tarda exhibits hyaline cuffs surrounding superficial vessels and solar elastosis in the adjacent skin. The disease frequently exhibits caterpillar bodies, subepidermal bullae, and festooning. Caterpillar bodies are eosinophilic, elongated, segmented structures found on the roofs of blisters, recognized as a distinct histopathological characteristic of porphyric bullous eruptions, such as porphyria cutanea tarda and erythropoietic protoporphyria.[5]

Oxalosis

Primary oxalosis is an autosomal recessive condition characterized by excessive serum oxalate production. Patients with this condition experience recurring episodes of calcium oxalate kidney stones and suffer from renal insufficiency. Vascular deposition of oxalate results in livedo reticularis, acrocyanosis, distal gangrene, and ulcerations. Secondary oxalosis can result from ethylene glycol poisoning, high ascorbic acid use, pyridoxine deficiency, various intestinal disorders, recurrent use of oral antibiotics resulting in the eradication of oxalate-degrading bacteria in the colon, and chronic hemodialysis. Cutaneous symptoms in patients with secondary oxalosis arise from extravascular deposits. These symptoms present as yellow-brown, radially arranged, refractile, needle-shaped crystals. Vascular involvement and thrombi may occur, particularly in primary disease.[6]

Vitamin Disturbances

Vitamins and micronutrients are essential for proper biological functioning and are critical for hair, nail, and skin health. Although nutrient deficiencies are rare within the general population, they are more common in individuals with malabsorption issues or limited food access. Some nutritional deficiencies can have marked cutaneous manifestations with corresponding histopathological clues. In contrast, other deficiencies can often be identified through laboratory studies and detailed history-taking, such as purpura in a patient with vitamin K deficiency.[7]

  • Scurvy is caused by a deficiency in vitamin C, a water-soluble vitamin primarily obtained from fruits and vegetables. Vitamin C, or ascorbic acid, is essential for the formation of mature collagen bundles in blood vessel walls and dermal structures.[8] Although rare in the United States—due to the modern availability of fruits, vegetables, and dietary supplements—cases of scurvy remain, particularly in underdeveloped countries. Patients classically present with cutaneous manifestations, including easy bruising, petechiae, gingival hemorrhage, follicular hyperkeratosis, and perifollicular hemorrhage (see Images. Scurvy Clinical 1 and Scurvy Clinical 2).[8][9] Additional clinical findings that can clue a clinician into the diagnosis include spontaneous breakdown of old wounds, corkscrew or swan-neck hairs, and hemarthrosis with minor trauma (see Image. Dermoscopy of Scurvy).[8] Importantly, scurvy can mimic several hematologic diseases and vasculitis.[10] Histopathological features mimic the clinical presentation, with extravasated erythrocytes around vessels in the dermis, soft keratin plugging follicular openings, and extravasated erythrocytes around hair follicles (see Image. Histopathology of Scurvy).[8][9] In addition, there are reports of superficial perivascular infiltrate and hemosiderin deposition following the degradation of erythrocytes.[8][10]
  • Vitamin A is a fat-soluble nutrient primarily obtained from vegetables and animal products and is essential for healthy skin and hair.[7][11] The active metabolites—retinoic acid and retinol—regulate follicular and melanocytic stem cell activity and contribute to the wound healing process.[11] Retinoids, which are vitamin A derivatives, regulate keratinocyte proliferation and differentiation.[12] Abnormal levels of vitamin A can alter the function of the skin and hair, leading to characteristic clinical findings. Although rare, vitamin A deficiency can present as dry and rough skin with prominent hyperkeratotic follicular papules and plaques on the extremities, trunk, face, and scalp (see Image. Vitamin A Deficiency).[7][13] Additional findings include night blindness and dry eyes. Histopathological findings include prominent dilatation, keratotic follicular plugging, and, in severe cases, sebocyte atrophy (see Image. Histopathology of Vitamin A Deficiency).[7][14] An excess of vitamin A can lead to adverse effects and is typically secondary to self-administration of high doses of vitamin A supplementation.[15][16] Patients classically present with diarrhea, patchy alopecia, cheilitis, skin desquamation, nausea, and dry eyes.[15] There are no specific histological findings in cases of excessive vitamin A.[17]
  • Pellagra is a multiorgan disease caused by a deficiency of niacin or tryptophan.[18] Similar to many nutritional deficiencies, this condition is more common in resource-limited settings but also occurs in developed nations. Pellagra is typically associated with intestinal malabsorption, alcoholism, anorexia nervosa, and specific medications.[18] Classic symptoms include the 3 D’s—dermatitis, diarrhea, and dementia.[18] Skin lesions typically begin as bright red, sunburn-like erythema, which slowly hyperpigments and may desquamate.[19] Skin changes are often photo-distributed, and glossitis and vulvitis also can occur.[18][19][20] Histopathological findings are not entirely specific and thus not diagnostic without clinical context. Epidermal atrophy and pallor may be present with overlying hyperkeratosis and parakeratosis (see Image. Histopathology of Pellagra).[18] Additional findings include mild spongiosis, dilated vessels in the superficial dermis with extravasation of erythrocytes, and keratinocyte ballooning.[18] In bullous lesions, the separation can be either intraepidermal or subepidermal, with direct immunofluorescence showing negative results.[18]

Necrolytic Erythemas

Necrolytic erythemas are a group of disorders with diverse metabolic origins that share similar histopathologic features. This category includes acrodermatitis enteropathica, glucagonoma syndrome, necrolytic acral erythema, and Hartnup disease.

  • Acrodermatitis enteropathica is a rare condition caused by zinc deficiency. Rare autosomal recessive defects in the zinc transporter protein ZIP4 encoded by SLC39A4 cause a classic triad of dermatitis, diarrhea, and alopecia.[21] The dermatitis primarily affects perioral, flexural, and acral skin. Additional clinical findings include nail dystrophy, glossitis, poor wound healing, and paronychia.[21][22] Zinc is a vital micronutrient essential for growth, local immunity, and wound healing. The autosomal recessive form of acrodermatitis enteropathica typically manifests within weeks of breastfeeding cessation, as breast milk contains higher concentrations of bioavailable zinc.[21] However, several acquired forms of zinc deficiency can present similarly and need to be considered, including anorexia nervosa, inflammatory bowel disease, parenteral nutrition, malnutrition, Hartnup disease, and cystic fibrosis.[21][22] Histopathological features of acrodermatitis enteropathica depend on the lesion's age and can be observed in other necrolytic erythemas, including glucagonoma syndrome.[23] Typical findings include necrolysis, which is characterized by the presence of cytoplasmic pallor, vacuolization, ballooning degeneration, and necrosis of the superficial stratum spinosum and stratum granulosum (see Image. Histopathology of Acrodermatitis Enteropathica).[24] The pallor of the epidermis alone is not diagnostically sufficient, as it can be observed in several other conditions, including pityriasis rubra pilaris, psoriasis, and contact dermatitis. Early lesions often show nonspecific findings such as confluent parakeratosis, hypogranulosis, and neutrophil crusting. Chronic lesions may exhibit psoriasiform hyperplasia, pallor, and variable amounts of neutrophils, making differentiation from psoriasis challenging. Findings associated with alopecia and nail dystrophy have not been well characterized.[24]
  • Glucagonomas are extremely rare neuroendocrine tumors that arise from the alpha cells of the pancreatic islets and can be associated with a range of paraneoplastic manifestations grouped under glucagonoma syndrome.[25][26] The characteristic clinical presentation includes stomatitis, glossitis, anemia, weight loss, diabetes mellitus, diarrhea, and necrolytic migratory erythema.[25] Necrolytic migratory erythema appears as annular and arcuate erythematous lesions in areas of high friction, such as the groin, axillae, popliteal and antecubital fossae, buttocks, lower abdomen, and distal extremities. Necrolytic migratory erythema is not specific to glucagonoma syndrome; it can also be observed in inflammatory bowel disease, liver disease, and other malignancies. The exact etiology of the lesions remains unclear; however, it is hypothesized that elevated circulating glucagon leads to an amino acid deficiency.[27] Histopathological features resemble those observed in acrodermatitis enteropathica, and findings depend on the lesion's chronicity and often show nonspecific subacute dermatitis.[27][28] Features also include parakeratosis, intraepidermal cleft formation with neutrophil infiltration, epidermal pallor, and spongiosis, along with perivascular lymphocytic and histiocytic infiltrates (see Image. Histopathology of Glucagonoma).[26][27][28] Chronic lesions may display acanthosis and dyskeratosis.[28]
  • Necrolytic acral erythema presents as well-defined hyperpigmented, pink-to-red papules and plaques on acral surfaces with thick, adherent scales, with a predilection for the lower extremities, particularly the dorsum of the feet.[29] This condition is typically observed in patients with chronic hepatitis C infections, but it has also been reported in conjunction with leukocytoclastic vasculitis and zinc deficiency. Histopathologically, lesions are indistinguishable from those of acrodermatitis enteropathica and glucagonoma syndrome; correlation with clinical features and laboratory work-up is essential. The epidermis may show acanthosis and spongiosis with superficial lymphocytic infiltrates in early lesions. More established lesions exhibit parakeratosis, papillomatosis, epidermal pallor, necrotic keratinocytes, and subcorneal neutrophils (see Image. Histopathology of Necrolytic Acral Erythema ).[29]
  • Hartnup disease is an autosomal recessive disorder caused by mutations in the gene SLC6A19, which affects gut absorption of tryptophan and renal tubule reabsorption of neutral amino acids.[30] Cutaneous lesions classically resemble pellagra and eruptions in areas of ultraviolet exposure.[31] Rarely, lesions can appear similar to acrodermatitis enteropathica.[32] Additional symptoms include progressive neurologic dysfunction, including tremors, ataxia, convulsions, and psychiatric disturbances.[30] Histopathologic findings are similar to those observed in pellagra.[31][33]

Lysosomal Storage Disorders

Lysosomal storage disorders are a diverse group of rare clinical conditions characterized by the accumulation of lipid byproducts, leading to deposition in various tissues, including the skin. Although neurologic symptoms are most common, few disorders present with skin lesions.

  • Gaucher disease is an autosomal recessive disorder with variable penetrance, where clinical manifestations can range from completely asymptomatic to lethal.[34][35] This disorder is the most common type of sphingolipidoses secondary to a deleterious mutation in the gene encoding glucocerebrosidase.[36] Patients can present with skeletal abnormalities and neurologic deficits. Skin findings are common in many sphingolipidoses, and in the lethal neonatal form, patients can present as a collodion or ichthyosiform skin changes; other skin lesions described include hyperpigmentation, brown macules, and easy tanning.[34] Despite the accumulation of glycolipids within macrophages, which stain positive with periodic acid-Schiff (PAS), dermatopathological findings remain elusive and unclassified.[35][37][38]
  • Fabry disease is a rare X-linked lysosomal storage disease caused by derangements in the function of alpha-galactosidase.[39] Classic Fabry disease is a multiorgan disorder involving cardiac, renal, and cerebrovascular systems, with a typical onset as early as the fifth decade of life.[39][40] Symptoms can include episodic fevers, pain in the distal extremities, extremity swelling, whorled corneal opacities, and angiokeratoma corporis diffusum.[39][40] Angiokeratoma corporis diffusum appears as many non-blanching red-to-dark-blue monomorphic papules with a sex-dependent distribution. In males, angiokeratoma corporis diffusum is localized most often to the genitalia, inner thighs, lower back, and buttocks; in females, lesions appear on the trunk and extremities.[39] Importantly, the presence of angiokeratomas is not unique to Fabry disease but can be observed in several other lysosomal storage disorders.[39] Light microscopy findings include dilated blood vessels in the superficial dermis with occasional fibrin thrombi, a thinned overlying epidermis, and varying amounts of hyperkeratosis (see Image. Histopathology of Angiokeratoma).[41] PAS-positive deposits in the vacuolized cells of the vessels and the sweat glands have also been described,[41][42] and the PAS-positive substance within endothelial-lined vessels can stain positive with Sudan black.[43]
  • Metachromatic leukodystrophy is an autosomal recessive lysosomal storage disorder secondary to a deficiency in the enzyme arylsulfatase A, which is required to hydrolyze sulfated glycosphingolipids. This deficiency leads to the accumulation of myelin byproducts, resulting in multiorgan disease, including the central nervous system, kidneys, and biliary tract.[44] Clinically, patients present with progressive psychological and neurologic deterioration, with the rate of decline existing on a spectrum.[44][45] Cutaneous lesions have not been documented, and hematoxylin and eosin staining of the skin in patients with metachromatic leukodystrophy has not been associated with any abnormalities.[46] However, there have been reports of vacuolated endoneurium within skin nerves. These vacuolated cells, when examined using cresyl violet staining on frozen sections, display brown metachromatic material.[44]
  • Disseminated lipogranulomatosis (Farber Disease) is a rare autosomal recessive disorder that results in the accumulation of ceramides due to a deficiency of lysosomal ceramidase.[47] The onset of disease is typically within the first few months of life with joint pain and swelling, hoarseness, stridor, muscle weakness, and psychomotor deterioration. Cutaneous lesions include subcutaneous or periarticular nodules and erythematous plaques.[47][48][49] Histopathology of subcutaneous nodules reveals granulomatous inflammation with varying amounts of cellularity and fibrosis.[48] Although some cells appear morphologically similar to foam cells, other reports document dermal foam cells, prominent fibrosis of the dermis and subcutis with bundles of collagen traversing in haphazard directions.[49][50] Spindled cells within the granulomas stain positive for PAS and mucopolysaccharide.[48] Additional findings indicate that Baker reaction was positive, and polysaccharide staining showed a positive result with oil red O.[51]
  • Krabbe disease is a rare autosomal recessive progressive neurologic disorder of childhood with an incidence of 1 in 100,000 live births in the United States.[52] Deficiency in the lysosomal enzyme galactocerebrosidase results in the accumulation of psychosine and the death of Schwann cells and oligodendrocytes within the nervous system.[52][53] The white matter of the central nervous system typically displays globoid cells, which have PAS-positive cytoplasm, but cutaneous nerves normally appear under light microscopy.[52][53]
  • Niemann-Pick disease is an autosomal recessive disease caused by mutations in the genes encoding the lysosomal enzyme sphingomyelinase, resulting in the accumulation of sphingomyelin and other lipid byproducts within tissues.[54][55][56] Over the past several decades, numerous genes and mutations have been implicated in the pathogenesis of Niemann-Pick disease.[54][55][56] Clinically, all patients experience progressive neurologic deterioration and eventual death during early childhood.[54][57] Additional clinical features are mutation-dependent, including hepatosplenomegaly, interstitial lung disease, thrombocytopenia, and ocular disturbances.[58] Cutaneous lesions are not classic but can include brown hyperpigmentation and brown indurated plaques,[59] facial papules,[60] juvenile xanthogranulomas,[61] erythematous and yellow papules, and deep-seated subcutaneous nodules.[62] On light microscopy, the brown plaques displayed dermal foamy histiocytes with scattered lymphocytes and plasma cells, similar to the appearance in other organs.[59] In a report, these foamy cells appeared brown on hematoxylin and eosin staining.[60] Deep-seated nodules revealed lobular panniculitis composed of a mixed inflammatory infiltrate and scattered ill-defined epithelioid granulomas.[62] Foamy cells stain with oil red O and Sudan black on frozen sections and appear metachromatic with toluidine blue.[60][63]

Miscellaneous Disorders

The following metabolic and storage disorders do not share a unifying theme. However, they are clinically relevant and are included for completeness.

  • Prolidase deficiency is a rare autosomal recessive inborn error of metabolism.[64] Mutations in prolidase, which processes iminodipeptides in collagen, result in recalcitrant and painful leg ulcerations.[64] Additional cutaneous symptoms include telangiectasia of the face and hands and photosensitivity. Patients typically also present with recurrent infections, dysmorphic facial features, intellectual disability, and organomegaly.[64] The histopathologic appearance is nonspecific, including ulceration with mild inflammation and vascular wall thickening with infiltration of mononuclear cells and neutrophils.[65][66] In addition, there are reports of amyloid deposition within vessel walls and the immediate surrounding dermis.[67]
  • Tangier disease is an autosomal recessive disorder caused by mutations in the ATP-binding cassette-1 gene (ABC1), resulting in a deficiency of normal high-density lipoprotein (HDL) within the plasma and accumulation of cholesterol within several organ systems.[68] Patients typically present with enlarged and yellow tonsils and neuropathy. Cutaneous lesions are infrequent, but papular lesions have been described.[68] Histopathological findings reveal perivascular and interstitial nests of foam cells with few lymphocytes and plasma cells. The cytoplasm of the foam cells stains positively with oil red O and Sudan black in frozen sections.[69] Cholesterol esters are doubly refractile and can be observed both intracellularly and extracellularly.[68][69]
  • Lafora disease is a genetic neurodegenerative disorder that classically presents with seizures, myoclonus, and dementia in adolescence. This disorder is due to mutations in either the laforin or malin genes.[70] Skin lesions are not typically present; however, biopsies of normal-appearing skin demonstrate PAS-positive, diastase-resistant inclusions within eccrine ducts and apocrine sweat ducts.[70]
  • Crohn disease and ulcerative colitis often present with many extra-intestinal manifestations, many of which are shared between the two conditions.[71] Up to 40% of patients with inflammatory bowel disease experience extracutaneous manifestations, more commonly in patients with Crohn disease.[71] The primary cutaneous manifestations include erythema nodosum, pyoderma gangrenosum, and aphthous stomatitis.[71] Additional cutaneous findings that are observed in both disorders include finger clubbing, cutaneous polyarteritis nodosa, erythema multiforme, vitiligo, psoriasis, and pyostomatitis vegetans.[71][72] Ulcerative colitis and Crohn disease are associated with clinical findings of erythema nodosum and pyoderma gangrenosum. Erythema nodosum often presents as tender, ill-defined red nodules on the pretibial legs with characteristic features of predominantly septal panniculitis adjacent to adipocyte lobules and composed of a mixed inflammatory infiltrate consisting of lymphocytes, histiocytes, eosinophils, and numerous neutrophils (see Image. Histopathology of Erythema Nodosum).[73] Similarly to erythema nodosum, pyoderma gangrenosum is a reactive, non-infectious inflammatory dermatosis; however, lesions are often extremely tender, erythematous nodules with a high propensity to ulcerate with ragged and undermined borders.[74] Interestingly, pyoderma gangrenosum is more commonly observed in patients with ulcerative colitis.[71][72] Lesions can vary in histopathologic appearance but classically display ulceration of the epidermis and dermis with an intense neutrophilic infiltrate, neutrophilic pustules, and abscess formation. Organism stains are negative, and there should be minimal evidence of vasculitis (see Image. Histopathology of Pyoderma Gangrenosum).[74] In Crohn disease, perianal lesions can include multi-lobed skin tags, fistulas, and abscesses.[71][72] The skin tags are commonly confused for condyloma acuminata, but a biopsy reveals dermal granulomas with overlying epidermal acanthosis.[71][72] Innumerable skin manifestations have been described in association with Crohn disease, including linear IgA disease, epidermolysis bullosa acquisita, pyoderma faciale, acrodermatitis enteropathica-like eruptions due to zinc deficiency, and neutrophilic dermatoses.[71][72] Metastatic Crohn disease refers to lesions that are not contiguous with the mucosa. These lesions can appear as nodular, plaque-like, or ulcerated and are often found in skin folds or extremities. Moreover, peristomal lesions can occur following bowel resection (see Image. Cutaneous Crohn Disease). A biopsy of these lesions reveals non-caseating granulomas, similar to mucosal lesions (see Image. Histopathology of Cutaneous Crohn Disease).[71][72]
  • Whipple disease is caused by the gram-positive bacterium Tropheryma whipplei and is most commonly reported in North America and Europe.[75] This systemic disorder is extremely rare, with only case reports in the literature, and is characterized by abdominal pain, signs and symptoms of malabsorption, arthritis, and neurologic manifestations.[75] Skin changes include hyperpigmentation of scars and sun-exposed skin.[75][76] In addition, there are reports of subcutaneous nodules, which, when biopsied, revealed PAS-positive macrophages within the subcutis.[77][78] These subcutaneous nodules may reveal septal panniculitis composed of foamy PAS-positive macrophages and neutrophils. Palisading granulomas with PAS-positive material in the center within the dermis and scattered dermal epithelioid histiocytes have also been reported.[79]
  • Cystic fibrosis is an autosomal recessive disorder affecting the cystic fibrosis conductance regular (CFTR) gene.[80] Cutaneous manifestations of cystic fibrosis are uncommon and may be secondary to malnutrition. These manifestations typically affect the extremities, perineum, and perioral surfaces and present as red, scaly, or desquamating papules and plaques.[81] Additional findings include purpura of the lower extremities, cutaneous vasculitis, and erythema nodosum. Histopathologic findings are nonspecific, including epidermal acanthosis and mild perivascular and interstitial lymphocytic infiltrates.[82]

Enhancing Healthcare Team Outcomes

Systemic metabolic disorders and rare cellular storage diseases often present with a variety of skin manifestations that can serve as early indicators of underlying conditions. These disorders may have genetic or behavioral causes, including vitamin disturbances, necrolytic erythemas, lysosomal storage diseases, mucinoses, amyloidosis, calcinosis cutis, gout, porphyria, oxalosis, and others. Skin findings can range from subtle to pronounced and often overlap with other conditions, making diagnosis challenging. Histopathologic features are frequently nonspecific, requiring careful correlation with clinical presentation to ensure accurate identification. Recognizing these cutaneous signs is essential for timely diagnosis and management of the associated systemic diseases.

Providing patient-centered care for individuals with metabolic and storage disorders affecting the skin requires collaboration among healthcare professionals, including clinicians, advanced practice practitioners, pharmacists, and other healthcare providers. Dermatopathologists should collaborate with dermatologists, primary providers, and other clinicians to understand the clinical scenario. Involving the entire interprofessional healthcare team allows for improved patient-centered care.

A strategic approach to managing these disorders is essential, incorporating evidence-based treatment plans while minimizing potential adverse effects. Ethical considerations, such as informed consent and respect for patient autonomy, should guide all decision-making processes. Each healthcare professional must know their responsibilities and contribute their unique expertise to the patient's care plan, fostering an interprofessional approach. Effective interprofessional communication is paramount, allowing seamless information exchange and collaborative decision-making among the team members. Care coordination ensures that the patient's journey from diagnosis to treatment and follow-up is well-managed, optimizing outcomes.

Media


(Click Image to Enlarge)
<p>Scurvy Clinical 1

Scurvy Clinical 1. The image illustrates classic cutaneous manifestations of scurvy, including easy bruising, petechiae, gingival hemorrhage, follicular hyperkeratosis, and perifollicular hemorrhage.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Scurvy Clinical 2

Scurvy Clinical 2. The image illustrates classic cutaneous manifestations of scurvy, including easy bruising, petechiae, gingival hemorrhage, follicular hyperkeratosis, and perifollicular hemorrhage.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Dermoscopy of Scurvy

Dermoscopy of Scurvy. The image shows dermoscopic findings associated with scurvy, including corkscrew or swan-neck hairs.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Histopathology of Scurvy

Histopathology of Scurvy. The image highlights characteristic histopathological features of scurvy, including extravasated erythrocytes around vessels in the dermis, soft keratin plugging follicular openings, and extravasated erythrocytes around hair follicles.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Vitamin A Deficiency

Vitamin A Deficiency. The image shows a patient displaying signs of vitamin A deficiency, characterized by dry, rough skin with prominent hyperkeratotic follicular papules and plaques.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Histopathology of Vitamin A Deficiency

Histopathology of Vitamin A Deficiency. The image depicts histopathological findings associated with vitamin A deficiency. Key features include prominent dilatation, keratotic follicular plugging, and, in severe cases, sebocyte atrophy.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Histopathology of Pellagra

Histopathology of Pellagra. The image illustrates histopathological findings associated with pellagra. Key features include epidermal atrophy and pallor, accompanied by overlying hyperkeratosis and parakeratosis.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Histopathology of Acrodermatitis Enteropathica

Histopathology of Acrodermatitis Enteropathica. The image illustrates typical histopathological findings of acrodermatitis enteropathica, including necrolysis marked by cytoplasmic pallor, vacuolization, ballooning degeneration, and necrosis within the superficial layers of the stratum spinosum and stratum granulosum.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Histopathology of Glucagonoma

Histopathology of Glucagonoma. The image demonstrates histopathological features of glucagonoma, including parakeratosis, intraepidermal cleft formation with neutrophil infiltration, epidermal pallor, and spongiosis, along with perivascular lymphocytic and histiocytic infiltrates.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Histopathology of Necrolytic Acral Erythema

Histopathology of Necrolytic Acral Erythema. Early lesions reveal acanthosis, spongiosis, and superficial lymphocytic infiltrates. In more advanced lesions, there is parakeratosis, papillomatosis, epidermal pallor, necrotic keratinocytes, and subcorneal neutrophils.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Histopathology of Angiokeratoma

Histopathology of Angiokeratoma. The image displays histopathological findings of angiokeratoma, including dilated blood vessels in the superficial dermis with occasional fibrin thrombi, a thinned overlying epidermis, and varying degrees of hyperkeratosis.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Histopathology of Erythema Nodosum

Histopathology of Erythema Nodosum. Key features include predominantly septal panniculitis adjacent to adipocyte lobules, characterized by a mixed inflammatory infiltrate of lymphocytes, histiocytes, eosinophils, and numerous neutrophils.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Histopathology of Pyoderma Gangrenosum

Histopathology of Pyoderma Gangrenosum. Classic findings include epidermal and dermal ulceration accompanied by a dense neutrophilic infiltrate, neutrophilic pustules, and abscess formation.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Cutaneous Crohn Disease

Cutaneous Crohn Disease. The image shows cutaneous manifestations of Crohn disease, including nodular, plaque-like, or ulcerated lesions.

Contributed by K Wanat, MD


(Click Image to Enlarge)
<p>Histopathology of Cutaneous Crohn Disease

Histopathology of Cutaneous Crohn Disease. The image shows a histopathological biopsy of cutaneous lesions in Crohn disease, highlighting non-caseating granulomas.

Contributed by K Wanat, MD

References


[1]

Lin IC, Chiu HY, Chan JY, Lin SJ. Extensive scleredema adultorum with loss of eccrine glands. Journal of the American Academy of Dermatology. 2014 Sep:71(3):e99-e101. doi: 10.1016/j.jaad.2014.03.040. Epub     [PubMed PMID: 25128148]


[2]

Nguyen VB, Nguyen VVH, Van Le C, Linh PNT, Thi XN, Vo TT. Pretibial myxedema in Grave's disease: A case report and treatment review of the literature. Clinical case reports. 2024 Feb:12(2):e8478. doi: 10.1002/ccr3.8478. Epub 2024 Feb 22     [PubMed PMID: 38389965]

Level 3 (low-level) evidence

[3]

Bandhlish A, Aggarwal A, Koranne RV. A clinico-epidemiological study of macular amyloidosis from north India. Indian journal of dermatology. 2012 Jul:57(4):269-74. doi: 10.4103/0019-5154.97662. Epub     [PubMed PMID: 22837559]

Level 2 (mid-level) evidence

[4]

Liu B, Xu G, Li H, Lu G, Ning N, Tang Q. Excessive collagen fiber deposition in idiopathic scrotal calcinosis: a case report. BMC urology. 2024 Oct 3:24(1):212. doi: 10.1186/s12894-024-01601-w. Epub 2024 Oct 3     [PubMed PMID: 39363259]

Level 3 (low-level) evidence

[5]

Fung MA, Murphy MJ, Hoss DM, Berke A, Grant-Kels JM. The sensitivity and specificity of "caterpillar bodies" in the differential diagnosis of subepidermal blistering disorders. The American Journal of dermatopathology. 2003 Aug:25(4):287-90     [PubMed PMID: 12876485]


[6]

Ly S, Rick J, Goff R, David BA, Kincannon J, Shalin S. Cutaneous Oxalosis Due to Primary Hyperoxaluria. The American Journal of dermatopathology. 2022 Dec 1:44(12):981-983. doi: 10.1097/DAD.0000000000002307. Epub     [PubMed PMID: 36395453]


[7]

Barthelemy H, Chouvet B, Cambazard F. Skin and mucosal manifestations in vitamin deficiency. Journal of the American Academy of Dermatology. 1986 Dec:15(6):1263-74     [PubMed PMID: 2948974]


[8]

Hirschmann JV, Raugi GJ. Adult scurvy. Journal of the American Academy of Dermatology. 1999 Dec:41(6):895-906; quiz 907-10     [PubMed PMID: 10570371]


[9]

Fossitt DD, Kowalski TJ. Classic skin findings of scurvy. Mayo Clinic proceedings. 2014 Jul:89(7):e61. doi: 10.1016/j.mayocp.2013.06.030. Epub     [PubMed PMID: 24996243]


[10]

Heibel HD, Ibad S, Chao Y, Patel KK, Hutto J, Redd LE, Nussenzveig DR, Laborde KH, Cockerell CJ, Shwin K. Scurvy and Tinea Corporis Simulating Leukocytoclastic Vasculitis. The American Journal of dermatopathology. 2021 Dec 1:43(12):e230-e233. doi: 10.1097/DAD.0000000000001993. Epub     [PubMed PMID: 34086641]


[11]

VanBuren CA, Everts HB. Vitamin A in Skin and Hair: An Update. Nutrients. 2022 Jul 19:14(14):. doi: 10.3390/nu14142952. Epub 2022 Jul 19     [PubMed PMID: 35889909]


[12]

Beckenbach L, Baron JM, Merk HF, Löffler H, Amann PM. Retinoid treatment of skin diseases. European journal of dermatology : EJD. 2015 Sep-Oct:25(5):384-91. doi: 10.1684/ejd.2015.2544. Epub     [PubMed PMID: 26069148]


[13]

Maronn M, Allen DM, Esterly NB. Phrynoderma: a manifestation of vitamin A deficiency?... The rest of the story. Pediatric dermatology. 2005 Jan-Feb:22(1):60-3     [PubMed PMID: 15660900]


[14]

Gómez-Diez S, Mas Vidal A, Soler T, Vázquez-López F, Pérez Oliva N. [Vitamin A deficiency and bowel-associated dermatosis-arthritis syndrome secondary to biliopancreatic diversion for obesity]. Actas dermo-sifiliograficas. 2010 Dec:101(10):900-2     [PubMed PMID: 21159272]


[15]

Silverman AK, Ellis CN, Voorhees JJ. Hypervitaminosis A syndrome: a paradigm of retinoid side effects. Journal of the American Academy of Dermatology. 1987 May:16(5 Pt 1):1027-39     [PubMed PMID: 3294938]


[16]

Roe DA. Assessment of risk factors for carotenodermia and cutaneous signs of hypervitaminosis A in college-aged populations. Seminars in dermatology. 1991 Dec:10(4):303-8     [PubMed PMID: 1764358]


[17]

Inkeles SB, Connor WE, Illingworth DR. Hepatic and dermatologic manifestations of chronic hypervitaminosis A in adults. Report of two cases. The American journal of medicine. 1986 Mar:80(3):491-6     [PubMed PMID: 2937294]

Level 3 (low-level) evidence

[18]

Piqué-Duran E, Pérez-Cejudo JA, Cameselle D, Palacios-Llopis S, García-Vázquez O. Pellagra: a clinical, histopathological, and epidemiological study of 7 cases. Actas dermo-sifiliograficas. 2012 Jan:103(1):51-8. doi: 10.1016/j.adengl.2011.05.003. Epub 2012 Mar 27     [PubMed PMID: 22456595]

Level 2 (mid-level) evidence

[19]

Hegyi J, Schwartz RA, Hegyi V. Pellagra: dermatitis, dementia, and diarrhea. International journal of dermatology. 2004 Jan:43(1):1-5     [PubMed PMID: 14693013]


[20]

Castiello RJ, Lynch PJ. Pellagra and the carcinoid syndrome. Archives of dermatology. 1972 Apr:105(4):574-7     [PubMed PMID: 4259595]


[21]

Sivakumar A, Vageshappa RK, Kumari R. Acrodermatitis Enteropathica. JAMA dermatology. 2024 Jan 1:160(1):102. doi: 10.1001/jamadermatol.2023.4147. Epub     [PubMed PMID: 37938848]


[22]

Ogawa Y, Kinoshita M, Shimada S, Kawamura T. Zinc and Skin Disorders. Nutrients. 2018 Feb 11:10(2):. doi: 10.3390/nu10020199. Epub 2018 Feb 11     [PubMed PMID: 29439479]


[23]

Gonzalez JR, Botet MV, Sanchez JL. The histopathology of acrodermatitis enteropathica. The American Journal of dermatopathology. 1982 Aug:4(4):303-11     [PubMed PMID: 7149179]


[24]

Maverakis E, Fung MA, Lynch PJ, Draznin M, Michael DJ, Ruben B, Fazel N. Acrodermatitis enteropathica and an overview of zinc metabolism. Journal of the American Academy of Dermatology. 2007 Jan:56(1):116-24     [PubMed PMID: 17190629]

Level 3 (low-level) evidence

[25]

Eldor R, Glaser B, Fraenkel M, Doviner V, Salmon A, Gross DJ. Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour. Clinical endocrinology. 2011 May:74(5):593-8. doi: 10.1111/j.1365-2265.2011.03967.x. Epub     [PubMed PMID: 21470282]


[26]

Hashizume T, Kiryu H, Noda K, Kano T, Nakano R. Glucagonoma syndrome. Journal of the American Academy of Dermatology. 1988 Aug:19(2 Pt 2):377-83     [PubMed PMID: 2842381]


[27]

Foss MG, Hashmi MF, Ferrer-Bruker SJ. Necrolytic Migratory Erythema. StatPearls. 2025 Jan:():     [PubMed PMID: 30422467]


[28]

Kovács RK, Korom I, Dobozy A, Farkas G, Ormos J, Kemény L. Necrolytic migratory erythema. Journal of cutaneous pathology. 2006 Mar:33(3):242-5     [PubMed PMID: 16466513]


[29]

Inamadar AC, Shivanna R, Ankad BS. Necrolytic Acral Erythema: Current Insights. Clinical, cosmetic and investigational dermatology. 2020:13():275-281. doi: 10.2147/CCID.S189175. Epub 2020 Apr 5     [PubMed PMID: 32308461]


[30]

Hashmi MS, Gupta V. Hartnup Disease. StatPearls. 2025 Jan:():     [PubMed PMID: 32644502]


[31]

Patel AB, Prabhu AS. Hartnup disease. Indian journal of dermatology. 2008 Jan:53(1):31-2. doi: 10.4103/0019-5154.39740. Epub     [PubMed PMID: 19967017]


[32]

Seyhan ME, Selimoğlu MA, Ertekin V, Fidanoğlu O, Altinkaynak S. Acrodermatitis enteropathica-like eruptions in a child with Hartnup disease. Pediatric dermatology. 2006 May-Jun:23(3):262-5     [PubMed PMID: 16780476]


[33]

Oakley A, Wallace J. Hartnup disease presenting in an adult. Clinical and experimental dermatology. 1994 Sep:19(5):407-8     [PubMed PMID: 7955499]


[34]

Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Hughes DA, Pastores GM. Gaucher Disease. GeneReviews(®). 1993:():     [PubMed PMID: 20301446]


[35]

Sidransky E. Gaucher disease: complexity in a "simple" disorder. Molecular genetics and metabolism. 2004 Sep-Oct:83(1-2):6-15     [PubMed PMID: 15464415]


[36]

Pastores GM. Gaucher's Disease. Pathological features. Bailliere's clinical haematology. 1997 Dec:10(4):739-49     [PubMed PMID: 9497861]


[37]

O'Brien JS, Bernett J, Veath ML, Paa D. Lysosomal storage disorders. Diagnosis by ultrastructural examination of skin biopsy specimens. Archives of neurology. 1975 Sep:32(9):592-9     [PubMed PMID: 809024]


[38]

Dolman CL. Diagnosis of neurometabolic disorders by examination of skin biopsies and lymphocytes. Seminars in diagnostic pathology. 1984 May:1(2):82-97     [PubMed PMID: 6100973]


[39]

Chan B, Adam DN. A Review of Fabry Disease. Skin therapy letter. 2018 Mar:23(2):4-6     [PubMed PMID: 29562089]

Level 3 (low-level) evidence

[40]

Bokhari SRA, Zulfiqar H, Hariz A. Fabry Disease. StatPearls. 2025 Jan:():     [PubMed PMID: 28613767]


[41]

Sagebiel RW, Parker F. Cutaneous lesions of Fabry's disease: glycolipid lipidosis; light and electron microscopic findings. The Journal of investigative dermatology. 1968 Mar:50(3):208-13     [PubMed PMID: 5644893]


[42]

Nakamura T, Kaneko H, Nishino I. Angiokeratoma corporis diffusum (Fabry disease): ultrastructural studies of the skin. Acta dermato-venereologica. 1981:61(1):37-41     [PubMed PMID: 6164212]


[43]

Luderschmidt C, Wolff HH. Subtle clues to diagnosis of skin diseases by electron microscopy. Intracytoplasmic granules with lamellae as signs of heterozygous Fabry's disease. The American Journal of dermatopathology. 1980 Spring:2(1):57-61     [PubMed PMID: 6787943]


[44]

Liaw HR, Lee HF, Chi CS, Tsai CR. Late infantile metachromatic leukodystrophy: Clinical manifestations of five Taiwanese patients and Genetic features in Asia. Orphanet journal of rare diseases. 2015 Nov 9:10():144. doi: 10.1186/s13023-015-0363-1. Epub 2015 Nov 9     [PubMed PMID: 26553228]


[45]

Gieselmann V. Metachromatic leukodystrophy: recent research developments. Journal of child neurology. 2003 Sep:18(9):591-4     [PubMed PMID: 14572136]


[46]

Chang XZ, Zhou JY, Yuan Y, Wu Y, Li YX, Zhang W, Jiang YW, Bao XH, Zhang YH, Wang S, Xiong H, Yang YL, Qin J. [Diagnostic value of muscle, sural nerve and skin biopsies in childhood neuromuscular disorders]. Zhonghua er ke za zhi = Chinese journal of pediatrics. 2006 Dec:44(12):909-12     [PubMed PMID: 17254458]

Level 2 (mid-level) evidence

[47]

Koga M. [Farber's lipogranulomatosis]. Nihon rinsho. Japanese journal of clinical medicine. 1995 Dec:53(12):3009-13     [PubMed PMID: 8577050]


[48]

Tanaka T, Takahashi K, Hakozaki H, Kimoto H, Suzuki Y. Farber's disease (disseminated lipogranulomatosis)--a pathological, histochemical and ultrastructural study--. Acta pathologica japonica. 1979 Jan:29(1):135-55     [PubMed PMID: 219658]


[49]

Chanoki M, Ishii M, Fukai K, Kobayashi H, Hamada T, Murakami K, Tanaka A. Farber's lipogranulomatosis in siblings: light and electron microscopic studies. The British journal of dermatology. 1989 Dec:121(6):779-85     [PubMed PMID: 2514784]


[50]

Schmoeckel C. Subtle clues to diagnosis of skin diseases by electron microscopy. "Farber bodies" in disseminated lipogranulomatosis (Farber's disease). The American Journal of dermatopathology. 1980 Summer:2(2):153-6     [PubMed PMID: 7246981]


[51]

Amirhakimi GH, Haghighi P, Ghalambor MA, Honari S. Familial lipogranulomatosis (Farber's disease). Clinical genetics. 1976 Jun:9(6):625-30     [PubMed PMID: 1277575]


[52]

Roy P, Chidambaranathan S, Ramesh S. Krabbe disease--a case report. Journal of the Indian Medical Association. 2005 Oct:103(10):548-50     [PubMed PMID: 16498763]

Level 3 (low-level) evidence

[53]

Tsvetkova IV, Zolotukhina TV, Rozenfel'd RA. [Biochemical diagnosis of globoid cell leukodystrophy (Krabbe's disease)]. Voprosy meditsinskoi khimii. 1985 Mar-Apr:31(2):128-30     [PubMed PMID: 2860752]


[54]

Mengel E, Bembi B, Del Toro M, Deodato F, Gautschi M, Grunewald S, Grønborg S, Héron B, Maier EM, Roubertie A, Santra S, Tylki-Szymanska A, Day S, Symonds T, Hudgens S, Patterson MC, Guldberg C, Ingemann L, Petersen NHT, Kirkegaard T, Í Dali C. Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study. Orphanet journal of rare diseases. 2020 Nov 23:15(1):328. doi: 10.1186/s13023-020-01616-0. Epub 2020 Nov 23     [PubMed PMID: 33228797]


[55]

Carsana EV, Lunghi G, Prioni S, Mauri L, Loberto N, Prinetti A, Zucca FA, Bassi R, Sonnino S, Chiricozzi E, Duga S, Straniero L, Asselta R, Soldà G, Samarani M, Aureli M. Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A. Journal of molecular neuroscience : MN. 2022 Jul:72(7):1482-1499. doi: 10.1007/s12031-022-02036-4. Epub 2022 Jun 21     [PubMed PMID: 35727525]


[56]

Thurberg BL, Wasserstein MP, Schiano T, O'Brien F, Richards S, Cox GF, McGovern MM. Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B). The American journal of surgical pathology. 2012 Aug:36(8):1234-46. doi: 10.1097/PAS.0b013e31825793ff. Epub     [PubMed PMID: 22613999]


[57]

Elleder M. Niemann-Pick disease. Pathology, research and practice. 1989 Sep:185(3):293-328     [PubMed PMID: 2682573]


[58]

Bajwa H, Azhar W. Niemann-Pick Disease. StatPearls. 2025 Jan:():     [PubMed PMID: 32310589]


[59]

Mardini MK, Gergen P, Akhtar M, Ghandour M. Niemann-Pick disease: report of a case with skin involvement. American journal of diseases of children (1960). 1982 Jul:136(7):650-1     [PubMed PMID: 7091102]

Level 3 (low-level) evidence

[60]

Toussaint M, Worret WI, Drosner M, Marquardt KH. Specific skin lesions in a patient with Niemann-Pick disease. The British journal of dermatology. 1994 Dec:131(6):895-7     [PubMed PMID: 7857847]


[61]

Wood WS, Dimmick JE, Dolman CL. Niemann-Pick disease and juvenile xanthogranuloma. Are they related? The American Journal of dermatopathology. 1987 Oct:9(5):433-7     [PubMed PMID: 3120613]


[62]

Bukhari I. Idiopathic nodular panniculitis in Niemann-Pick disease. Journal of the European Academy of Dermatology and Venereology : JEADV. 2005 Sep:19(5):600-2     [PubMed PMID: 16164717]


[63]

CROCKER AC, FARBER S. Niemann-Pick disease: a review of eighteen patients. Medicine. 1958 Feb:37(1):1-95     [PubMed PMID: 13516139]


[64]

Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Rossignol F, Wang H, Ferreira C. Prolidase Deficiency. GeneReviews(®). 1993:():     [PubMed PMID: 26110198]


[65]

Yasuda K, Ogata K, Kariya K, Kodama H, Zhang J, Sugahara K, Sagara Y, Kodama H. Corticosteroid treatment of prolidase deficiency skin lesions by inhibiting iminodipeptide-primed neutrophil superoxide generation. The British journal of dermatology. 1999 Nov:141(5):846-51     [PubMed PMID: 10583165]


[66]

Adışen E, Erduran FB, Ezgü FS, Kasapkara ÇS, Besio R, Forlino A, Gürer MA. A Rare Cause of Lower Extremity Ulcers: Prolidase Deficiency. The international journal of lower extremity wounds. 2016 Mar:15(1):86-91. doi: 10.1177/1534734615619550. Epub 2015 Dec 4     [PubMed PMID: 26637345]


[67]

Pierard GE, Cornil F, Lapiere CM. Pathogenesis of ulcerations in deficiency of prolidase. The role of angiopathy and of deposits of amyloid. The American Journal of dermatopathology. 1984 Oct:6(5):491-7     [PubMed PMID: 6507815]


[68]

Ferrans VJ, Fredrickson DS. The pathology of Tangier disease. A light and electron microscopic study. The American journal of pathology. 1975 Jan:78(1):101-58     [PubMed PMID: 162820]


[69]

Waldorf DS, Levy RI, Fredrickson DS. Cutaneous cholesterol ester deposition in Tangier disease. Archives of dermatology. 1967 Feb:95(2):161-5     [PubMed PMID: 6018991]


[70]

Rozenova KA, Lehman JS, Grande JP, Fine AL, Wieland CN. Utilization of skin biopsy for diagnosis in a case of Lafora disease. Journal of cutaneous pathology. 2022 Oct:49(10):885-888. doi: 10.1111/cup.14275. Epub 2022 Jul 6     [PubMed PMID: 35708461]

Level 3 (low-level) evidence

[71]

Antonelli E, Bassotti G, Tramontana M, Hansel K, Stingeni L, Ardizzone S, Genovese G, Marzano AV, Maconi G. Dermatological Manifestations in Inflammatory Bowel Diseases. Journal of clinical medicine. 2021 Jan 19:10(2):. doi: 10.3390/jcm10020364. Epub 2021 Jan 19     [PubMed PMID: 33477990]


[72]

Bezzio C, Della Corte C, Vernero M, Di Luna I, Manes G, Saibeni S. Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations. Therapeutic advances in gastroenterology. 2022:15():17562848221115312. doi: 10.1177/17562848221115312. Epub 2022 Jul 28     [PubMed PMID: 35924080]

Level 3 (low-level) evidence

[73]

Pérez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, Gomez-Flores M. Erythema Nodosum: A Practical Approach and Diagnostic Algorithm. American journal of clinical dermatology. 2021 May:22(3):367-378. doi: 10.1007/s40257-021-00592-w. Epub 2021 Mar 8     [PubMed PMID: 33683567]


[74]

George C, Deroide F, Rustin M. Pyoderma gangrenosum - a guide to diagnosis and management . Clinical medicine (London, England). 2019 May:19(3):224-228. doi: 10.7861/clinmedicine.19-3-224. Epub     [PubMed PMID: 31092515]


[75]

Antunes C, Singhal M. Whipple Disease. StatPearls. 2025 Jan:():     [PubMed PMID: 28722966]


[76]

Batista M, Santos ML, Silva C, Pereira G, Alves G, Cotter J. Whipple's Disease: A Case Report. Cureus. 2023 Jun:15(6):e39963. doi: 10.7759/cureus.39963. Epub 2023 Jun 5     [PubMed PMID: 37415994]


[77]

Feldman M. Whipple's disease. The American journal of the medical sciences. 1986 Jan:291(1):56-67     [PubMed PMID: 2417481]


[78]

Tarroch X, Vives P, Salas A, Moré J. Subcutaneous nodules in Whipple's disease. Journal of cutaneous pathology. 2001 Aug:28(7):368-70     [PubMed PMID: 11437943]


[79]

Canal L, Fuente Dde L, Rodriguez-Moreno J, Penin RM, Marcoval J. Specific cutaneous involvement in Whipple disease. The American Journal of dermatopathology. 2014 Apr:36(4):344-6. doi: 10.1097/DAD.0000000000000008. Epub     [PubMed PMID: 24562051]


[80]

Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. The New England journal of medicine. 2005 May 12:352(19):1992-2001     [PubMed PMID: 15888700]


[81]

Darmstadt GL, Schmidt CP, Wechsler DS, Tunnessen WW, Rosenstein BJ. Dermatitis as a presenting sign of cystic fibrosis. Archives of dermatology. 1992 Oct:128(10):1358-64     [PubMed PMID: 1417024]


[82]

Luu LA, Guffey DJ, Zlotoff BJ. Arthropathy and Cutaneous Eruption in a Patient With Cystic Fibrosis. JAMA dermatology. 2019 Mar 1:155(3):375-376. doi: 10.1001/jamadermatol.2018.5018. Epub     [PubMed PMID: 30673074]